KENNETH BOWMAN: Open Payments
NPI 1144478801 · RIPON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 49 payments from 14 companies in 2025. Trend: 2023 $650 · 2024 $857 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $291 |
| Amgen Inc. | 7 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82 |
| Lilly USA, LLC | 3 | $74 |
| Novo Nordisk Inc | 3 | $65 |
| PFIZER INC. | 4 | $57 |
| ABBVIE INC. | 2 | $56 |
| Exact Sciences Corporation | 2 | $54 |
| Lundbeck LLC | 2 | $49 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $32 |
Products named: AIRSUPRA, BREZTRI, JARDIANCE, REXULTI, EVENITY, NURTEC ODT, Cologuard Collection Kit, MOUNJARO.
Industry payments across CA — which companies pay providers there.
